Ocugen, Inc.
Status: Publicly traded
Direct answer
Ocugen, Inc. is publicly traded on NASDAQ under the ticker OCGN.
Ocugen, Inc. is a biopharmaceutical company in the clinical development phase, primarily dedicated to pioneering gene therapies aimed at treating various ophthalmic conditions leading to blindness. The company's developmental pipeline features several key candidates: OCU400: An innovative gene therapy designed to reinstate both the function and structural integrity of the retina across a broad spectrum of...
Can you invest in Ocugen, Inc.?
Yes. Ocugen, Inc. trades publicly on NASDAQ as OCGN.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Ocugen, Inc.
Detailed equity research is provided by MarketSnap.